Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Capital Work in Progress

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹2,739 Cr₹4,496 Cr₹2,938 Cr₹2,429 Cr₹1,622 Cr

What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?

The latest Capital Work in Progress ratio of AUROBINDO PHARMA is ₹2,739 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹2,739 Cr
Mar2023₹4,496 Cr
Mar2022₹2,938 Cr
Mar2021₹2,429 Cr
Mar2020₹1,622 Cr

How is Capital Work in Progress of AUROBINDO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹2,739 Cr
-39.08
Mar2023 ₹4,496 Cr
53.07
Mar2022 ₹2,938 Cr
20.94
Mar2021 ₹2,429 Cr
49.77
Mar2020 ₹1,622 Cr -

Compare Capital Work in Progress of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹66,437.7 Cr -2.3% -4.8% -8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,420.0 Cr -0.2% -2.9% 12.6% Stock Analytics
DIVIS LABORATORIES ₹177,572.0 Cr 0.3% 6.5% 49% Stock Analytics
CIPLA ₹123,329.0 Cr 1.1% 1.8% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,396.0 Cr -0.2% 9.5% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,956.0 Cr 1.9% 0.4% 14% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.3%

-4.8%

-8.4%

SENSEX

-0.8%

-0.9%

6.9%


You may also like the below Video Courses